FDA approves CRM monitoring system

Candace Stuart | | Cardiovascular Business | Heart Rhythm

The FDA approved Smartview technology to remotely monitor patients with implanted cardiac rhythm management (CRM) devices. The system allows patients to transmit data electronically from implanted cardiac devices to their physicians.

The system uses Smartview and Paradym RF devices, according to manufacturer Sorin Group, which initiated its U.S. launch of the Paradym RF VR and DR implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices in May 2012.

The Milan, Italy-based company said it was now beginning its launch of Smartview in the U.S.

Candace Stuart, Contributor

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup